HomeCompareBSEFY vs PFE

BSEFY vs PFE: Dividend Comparison 2026

BSEFY yields 2.72% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $28.1K in total portfolio value· pulled ahead in Year 9
10 years
BSEFY
BSEFY
● Live price
2.72%
Share price
$15.10
Annual div
$0.41
5Y div CAGR
-17.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$44.14
Full BSEFY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — BSEFY vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBSEFYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BSEFY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BSEFY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BSEFY
Annual income on $10K today (after 15% tax)
$230.79/yr
After 10yr DRIP, annual income (after tax)
$37.52/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,282.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BSEFY + PFE for your $10,000?

BSEFY: 50%PFE: 50%
100% PFE50/50100% BSEFY
Portfolio after 10yr
$35.5K
Annual income
$13,151.43/yr
Blended yield
37.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

BSEFY
No analyst data
Altman Z
1.5
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BSEFY buys
0
PFE buys
0
No recent congressional trades found for BSEFY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBSEFYPFE
Forward yield2.72%6.13%
Annual dividend / share$0.41$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-17.3%13.2%
Portfolio after 10y$21.4K$49.6K
Annual income after 10y$44.14$26,258.71
Total dividends collected$1.1K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BSEFY vs PFE ($10,000, DRIP)

YearBSEFY PortfolioBSEFY Income/yrPFE PortfolioPFE Income/yrGap
1$10,925$224.55$9,153$693.39+$1.8KBSEFY
2$11,879$189.60$8,593$849.25+$3.3KBSEFY
3$12,870$159.34$8,336$1,066.78+$4.5KBSEFY
4$13,904$133.43$8,437$1,384.80+$5.5KBSEFY
5$14,989$111.41$9,013$1,875.40+$6.0KBSEFY
6$16,131$92.83$10,306$2,680.72+$5.8KBSEFY
7$17,337$77.21$12,820$4,101.38+$4.5KBSEFY
8$18,615$64.14$17,673$6,826.70+$942.00BSEFY
9← crossover$19,971$53.23$27,543$12,591.86$7.6KPFE
10$21,413$44.14$49,560$26,258.71$28.1KPFE

BSEFY vs PFE: Complete Analysis 2026

BSEFYStock

Benesse Holdings, Inc. provides educational, senior nursing care, and childcare services in Japan and internationally. The company operates through four segments: Domestic Education, Global Kodomo Challenge, Nursing Care and Childcare, and Berlitz. The Domestic Education segment engages in the correspondence course business, school and teacher support business, cram and prep school business, English language classes for children business, and other businesses for primary school students to high school students. The Global Kodomo Challenge segment is involved in the correspondence course business in Japan, China, Taiwan, and Indonesia, primarily targeting infants. The Nursing Care and Childcare segment engages in the residential care services business, which include the operation of nursing homes and elderly homes; home helper services business; training courses for nursing care personnel; a staff placement and personnel dispatch company specializing in medical and nursing care personnel; the daycare and afterschool childcare operations business; and other businesses. The Berlitz segment is involved in the language instruction business; the ELS business, which provides educational services, including language training to those who want to study abroad; the worldwide leadership training business; and other businesses. It also offers interpretation and translation services; information and products relating to pregnancy, childbirth, and parenting; lifestyle information and support everyday living through forums for communication with customers; and magazines, websites, and others to help enrich life with pets. The company was formerly known as Benesse Corporation and changed its name to Benesse Holdings, Inc. in 2009. Benesse Holdings, Inc. was founded in 1955 and is headquartered in Okayama, Japan.

Full BSEFY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this BSEFY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BSEFY vs SCHDBSEFY vs JEPIBSEFY vs OBSEFY vs KOBSEFY vs MAINBSEFY vs JNJBSEFY vs MRKBSEFY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.